Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Pathogen reduced plasma products: a clinical practice scientific review from the AABB.

Cushing MM, Pagano MB, Jacobson J, Schwartz J, Grossman BJ, Kleinman S, Han MA, Cohn CS; AABB Clinical Transfusion Medicine Committee.

Transfusion. 2019 Jul 3. doi: 10.1111/trf.15435. [Epub ahead of print]

PMID:
31268584
2.

Fibrinogen concentrate for perioperative bleeding: what can we learn from the clinical trials?

Cushing MM, Haas T.

Transfusion. 2019 Jul 2. doi: 10.1111/trf.15437. [Epub ahead of print] Review.

PMID:
31267541
3.

Critical developments of 2018: A review of the literature from selected topics in transfusion. A committee report from the AABB's Clinical Transfusion Medicine Committee.

Cohn CS, Allen ES, Cushing MM, Dunbar NM, Friedman DF, Goel R, Harm SK, Heddle N, Hopkins CK, Klapper E, Perumbeti A, Ramsey G, Raval JS, Schwartz J, Shaz BH, Spinella PC, Pagano MB.

Transfusion. 2019 Aug;59(8):2733-2748. doi: 10.1111/trf.15348. Epub 2019 May 30.

PMID:
31148175
4.

International Study of the Epidemiology of Platelet Transfusions in Critically Ill Children With an Underlying Oncologic Diagnosis.

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, Tucci M, Stanworth SJ, Spinella PC; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Pediatric Critical Care Blood Research Network (BloodNet), and the Point Prevalence Study of Platelet Transfusions in Critically Ill Children (P3T) Investigators.

Pediatr Crit Care Med. 2019 Jul;20(7):e342-e351. doi: 10.1097/PCC.0000000000001987.

PMID:
31107379
5.

Red blood cells donated by smokers: A pilot investigation of recipient transfusion outcomes.

DeSimone RA, Hayden JA, Mazur CA, Vasovic LV, Sachais BS, Zhao Z, Goel R, Hsu YS, Racine-Brzostek SE, Cushing MM.

Transfusion. 2019 Aug;59(8):2537-2543. doi: 10.1111/trf.15339. Epub 2019 May 10.

PMID:
31074905
6.

The power of a trained eye: fatal transfusion-transmitted anaplasmosis and a case study in investigative work.

Goel R, Vasovic LV, Westblade LF, Harris R, D'Ambrosio D, Emmons F, Lo D, Hsu YS, Jenkins SG, Cushing MM.

Transfusion. 2019 Feb;59(2):444-445. doi: 10.1111/trf.14899. No abstract available.

PMID:
30727038
7.

Efficacy of a new pathogen-reduced cryoprecipitate stored 5 days after thawing to correct dilutional coagulopathy in vitro.

Cushing MM, Asmis LM, Harris RM, DeSimone RA, Hill S, Ivascu N, Haas T.

Transfusion. 2019 May;59(5):1818-1826. doi: 10.1111/trf.15157. Epub 2019 Feb 4.

PMID:
30719724
8.

The impact of Daratumumab on transfusion service costs.

Cushing MM, DeSimone RA, Goel R, Hsu YS, Parra P, Racine-Brzostek SE, Degtyaryova D, Lo DT, Morrison M, Crowley KM, Rossi A, Vasovic LV.

Transfusion. 2019 Apr;59(4):1252-1258. doi: 10.1111/trf.15134. Epub 2019 Jan 8.

PMID:
30620407
9.

Factors associated with red blood cell, platelet, and plasma transfusions among inpatient hospitalizations: a nationally representative study in the United States.

Goel R, Patel EU, White JL, Chappidi MR, Ness PM, Cushing MM, Takemoto CM, Shaz BH, Frank SM, Tobian AAR.

Transfusion. 2019 Feb;59(2):500-507. doi: 10.1111/trf.15088. Epub 2018 Dec 12.

PMID:
30548491
10.

Heparin-induced thrombocytopenia suggested by microscopic examination of a below-knee amputation.

DeSimone RA, Cushing MM.

Transfusion. 2018 Dec;58(12):2784-2785. doi: 10.1111/trf.14815. No abstract available.

PMID:
30520089
11.

Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.

Nellis ME, Goel R, Karam O, Cushing MM, Davis PJ, Steiner ME, Tucci M, Stanworth SJ, Spinella PC; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network, Pediatric Critical Care Blood Research Network (BloodNet), and the P3T Investigators; P3T Investigators.

Pediatr Crit Care Med. 2019 Feb;20(2):e61-e69. doi: 10.1097/PCC.0000000000001779.

PMID:
30422914
12.

Death from Transfusion-Transmitted Anaplasmosis, New York, USA, 2017.

Goel R, Westblade LF, Kessler DA, Sfeir M, Slavinski S, Backenson B, Gebhardt L, Kane K, Laurence J, Scherr D, Bussel J, Dumler JS, Cushing MM.

Emerg Infect Dis. 2018 Aug;24(8):1548-1550. doi: 10.3201/eid2408.172048. Erratum in: Emerg Infect Dis. 2018 Sep;24(9):1773.

13.

Association of Perioperative Red Blood Cell Transfusions With Venous Thromboembolism in a North American Registry.

Goel R, Patel EU, Cushing MM, Frank SM, Ness PM, Takemoto CM, Vasovic LV, Sheth S, Nellis ME, Shaz B, Tobian AAR.

JAMA Surg. 2018 Sep 1;153(9):826-833. doi: 10.1001/jamasurg.2018.1565.

14.

Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.

Reich-Slotky R, Makhani SS, Vasovic LV, Pearse RN, Rossi A, Philips A, Cushing MM, Singh AD, van Besien K.

Leuk Lymphoma. 2018 Dec;59(12):2829-2835. doi: 10.1080/10428194.2018.1455975. Epub 2018 May 23.

PMID:
29790808
15.

Usefulness of multiple electrode aggregometry as a screening tool for bleeding disorders in a pediatric hospital.

Haas T, Cushing MM, Varga S, Gilloz S, Schmugge M.

Platelets. 2019;30(4):498-505. doi: 10.1080/09537104.2018.1475631. Epub 2018 May 22.

PMID:
29787319
16.

Platelet Transfusion Practices in Critically Ill Children.

Nellis ME, Karam O, Mauer E, Cushing MM, Davis PJ, Steiner ME, Tucci M, Stanworth SJ, Spinella PC; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) network, Pediatric Critical Care Blood Research Network (BloodNet), and the P3T Investigators.

Crit Care Med. 2018 Aug;46(8):1309-1317. doi: 10.1097/CCM.0000000000003192.

17.

Logistical and safety implications of temperature-based acceptance of returned red blood cell units.

DeSimone RA, Nowak MD, Lo DT, Crowley KM, Parra P, Cushing MM, Hsu YS.

Transfusion. 2018 Jun;58(6):1500-1505. doi: 10.1111/trf.14615. Epub 2018 Apr 6.

PMID:
29624677
18.

Critical developments of 2017: a review of the literature from selected topics in transfusion. A committee report from the AABB Clinical Transfusion Medicine Committee.

Cushing MM, Kelley J, Klapper E, Friedman DF, Goel R, Heddle NM, Hopkins CK, Karp JK, Pagano MB, Perumbeti A, Ramsey G, Roback JD, Schwartz J, Shaz BH, Spinella PC, Cohn CS, Cohn CS, Cushing MM, Kelley J, Klapper E.

Transfusion. 2018 Apr;58(4):1065-1075. doi: 10.1111/trf.14520. Epub 2018 Mar 9. Review.

PMID:
29520794
19.

Trends in Red Blood Cell, Plasma, and Platelet Transfusions in the United States, 1993-2014.

Goel R, Chappidi MR, Patel EU, Ness PM, Cushing MM, Frank SM, Tobian AAR.

JAMA. 2018 Feb 27;319(8):825-827. doi: 10.1001/jama.2017.20121. No abstract available.

20.

Comparison of the efficacy of two human fibrinogen concentrates to treat dilutional coagulopathy in vitro.

Haas T, Cushing MM, Asmis LM.

Scand J Clin Lab Invest. 2018 May;78(3):230-235. doi: 10.1080/00365513.2018.1437645. Epub 2018 Feb 15.

PMID:
29446989
21.

Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults.

Tsai SB, Rhodes J, Liu H, Shore T, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS.

Biol Blood Marrow Transplant. 2018 May;24(5):997-1004. doi: 10.1016/j.bbmt.2017.12.794. Epub 2017 Dec 27.

22.

Validating and implementing the use of an infusion pump for the administration of thawed hematopoietic progenitor cells-a single-institution experience.

Reich-Slotky R, Cushing MM, Hsu YS, Ancharski M, Rojas JM, Scrimenti LM, Robilio S, Assalone D, Roselli T, Guarneri D, Vasovic LV, Goel R, Shore T, van Besien K.

Transfusion. 2018 Feb;58(2):339-344. doi: 10.1111/trf.14409. Epub 2017 Nov 29.

PMID:
29193156
23.

Influence of cryoprecipitate, Factor XIII, and fibrinogen concentrate on hyperfibrinolysis.

Cushing MM, Fitzgerald MM, Harris RM, Asmis LM, Haas T.

Transfusion. 2017 Oct;57(10):2502-2510. doi: 10.1111/trf.14259. Epub 2017 Jul 21.

PMID:
28734018
24.

Historical ABO blood group discrepancy: a blessing in disguise to unravel a medical identity theft.

Mulvey JJ, Matnani R, Cushing MM.

Transfusion. 2017 Apr;57(4):1096-1097. doi: 10.1111/trf.14052. No abstract available.

PMID:
28394425
25.

Pediatric Patient Blood Management Programs: Not Just Transfusing Little Adults.

Goel R, Cushing MM, Tobian AA.

Transfus Med Rev. 2016 Oct;30(4):235-41. doi: 10.1016/j.tmrv.2016.07.004. Epub 2016 Aug 1. Review.

PMID:
27559005
26.

Cryoprecipitate indications and patterns of use in the pediatric intensive care unit: inappropriate transfusions and lack of standardization.

DeSimone RA, Nellis ME, Goel R, Haas T, Vasovic L, Cushing MM.

Transfusion. 2016 Aug;56(8):1960-4. doi: 10.1111/trf.13649. Epub 2016 May 17.

PMID:
27185359
27.

Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma.

Cushing MM, Asmis L, Calabia C, Rand JH, Haas T.

Transfus Apher Sci. 2016 Aug;55(1):114-9. doi: 10.1016/j.transci.2016.04.015. Epub 2016 Apr 26.

PMID:
27156966
28.

Autologous Stem Cell Mobilization and Collection.

Hsu YM, Cushing MM.

Hematol Oncol Clin North Am. 2016 Jun;30(3):573-89. doi: 10.1016/j.hoc.2016.01.004. Review.

PMID:
27112997
29.

Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning.

Tsai SB, Liu H, Shore T, Fan Y, Bishop M, Cushing MM, Gergis U, Godley L, Kline J, Larson RA, Martinez G, Mayer S, Odenike O, Stock W, Wickrema A, van Besien K, Artz AS.

Biol Blood Marrow Transplant. 2016 Jun;22(6):1065-1072. doi: 10.1016/j.bbmt.2016.02.010. Epub 2016 Feb 19.

30.

Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.

van Besien K, Hari P, Zhang MJ, Liu HT, Stock W, Godley L, Odenike O, Larson R, Bishop M, Wickrema A, Gergis U, Mayer S, Shore T, Tsai S, Rhodes J, Cushing MM, Korman S, Artz A.

Haematologica. 2016 May;101(5):634-43. doi: 10.3324/haematol.2015.138594. Epub 2016 Feb 11.

31.

Engraftment for CD34 selected stem cell products is not compromised by cryopreservation.

Reich-Slotky R, Bachegowda LS, Ancharski M, Gergis U, van Besien K, Cushing MM.

Transfusion. 2016 Apr;56(4):893-8. doi: 10.1111/trf.13435. Epub 2015 Dec 12.

PMID:
26661996
32.

A novel bioreactor and culture method drives high yields of platelets from stem cells.

Avanzi MP, Oluwadara OE, Cushing MM, Mitchell ML, Fischer S, Mitchell WB.

Transfusion. 2016 Jan;56(1):170-8. doi: 10.1111/trf.13375. Epub 2015 Oct 15.

PMID:
26467770
33.

Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease.

DeSimone RA, Mitsios JV, Kucine N, Goss CA, Chadburn A, Cushing MM.

Transfusion. 2015 Oct;55(10):2304. doi: 10.1111/trf.13177. No abstract available.

PMID:
26459962
34.

Economic aspects of intraoperative coagulation management targeting higher fibrinogen concentrations during major craniosynostosis surgery.

Haas T, Spielmann N, Restin T, Schmidt AR, Schmugge M, Cushing MM.

Paediatr Anaesth. 2016 Jan;26(1):77-83. doi: 10.1111/pan.12784. Epub 2015 Oct 12.

PMID:
26457895
35.

Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection.

Price TH, Boeckh M, Harrison RW, McCullough J, Ness PM, Strauss RG, Nichols WG, Hamza TH, Cushing MM, King KE, Young JA, Williams E, McFarland J, Holter Chakrabarty J, Sloan SR, Friedman D, Parekh S, Sachais BS, Kiss JE, Assmann SF.

Blood. 2015 Oct 29;126(18):2153-61. doi: 10.1182/blood-2015-05-645986. Epub 2015 Sep 2.

36.

Effects of red-cell storage duration on patients undergoing cardiac surgery.

Steiner ME, Ness PM, Assmann SF, Triulzi DJ, Sloan SR, Delaney M, Granger S, Bennett-Guerrero E, Blajchman MA, Scavo V, Carson JL, Levy JH, Whitman G, D'Andrea P, Pulkrabek S, Ortel TL, Bornikova L, Raife T, Puca KE, Kaufman RM, Nuttall GA, Young PP, Youssef S, Engelman R, Greilich PE, Miles R, Josephson CD, Bracey A, Cooke R, McCullough J, Hunsaker R, Uhl L, McFarland JG, Park Y, Cushing MM, Klodell CT, Karanam R, Roberts PR, Dyke C, Hod EA, Stowell CP.

N Engl J Med. 2015 Apr 9;372(15):1419-29. doi: 10.1056/NEJMoa1414219.

37.

Evaluation of the minimum volume of salvage blood required for the successful use of two different autotransfusion devices.

Baumann C, Lamesic G, Weiss M, Cushing MM, Haas T.

Paediatr Anaesth. 2015 Mar;25(3):258-64. doi: 10.1111/pan.12535. Epub 2014 Sep 30.

PMID:
25267461
38.

Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia.

Arinsburg SA, Shaz BH, Westhoff C, Cushing MM.

Am J Hematol. 2012 May;87(5):525-8. doi: 10.1002/ajh.23111. Epub 2012 Feb 17. Review.

39.

A survey to assess transfusion medicine education needs for clinicians.

Arinsburg SA, Skerrett DL, Friedman MT, Cushing MM.

Transfus Med. 2012 Feb;22(1):44-9; quiz 49-51. doi: 10.1111/j.1365-3148.2011.01118.x. Epub 2011 Dec 5.

PMID:
22141339
40.

Conversion to low transfusion-related acute lung injury (TRALI)-risk plasma significantly reduces TRALI.

Arinsburg SA, Skerrett DL, Karp JK, Ness PM, Jhang J, Padmanabhan A, Gibble J, Schwartz J, King KE, Cushing MM.

Transfusion. 2012 May;52(5):946-52. doi: 10.1111/j.1537-2995.2011.03403.x. Epub 2011 Nov 7.

PMID:
22060800
41.

The significance of a positive DAT in thalassemia patients.

Arinsburg SA, Skerrett DL, Kleinert D, Giardina PJ, Cushing MM.

Immunohematology. 2010;26(3):87-91.

PMID:
21214294
42.

Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.

Tormey CA, Peddinghaus ME, Erickson M, King KE, Cushing MM, Bill J, Goodrich T, Snyder EL.

Transfusion. 2010 Feb;50(2):471-7. doi: 10.1111/j.1537-2995.2009.02412.x. Epub 2009 Oct 5.

PMID:
19804570
43.

Oxygen therapeutics: perfluorocarbons and blood substitute safety.

Cohn CS, Cushing MM.

Crit Care Clin. 2009 Apr;25(2):399-414, Table of Contents. doi: 10.1016/j.ccc.2008.12.007. Review.

PMID:
19341916
44.

Prognostic significance of flow cytometric immunophenotyping in acute myeloid leukemia.

Webber BA, Cushing MM, Li S.

Int J Clin Exp Pathol. 2008 Jan 1;1(2):124-33.

45.

Oxygen therapeutics: pursuit of an alternative to the donor red blood cell.

Ness PM, Cushing MM.

Arch Pathol Lab Med. 2007 May;131(5):734-41. Review.

PMID:
17488158
46.

Fatal West Nile virus encephalitis in a renal transplant recipient.

Cushing MM, Brat DJ, Mosunjac MI, Hennigar RA, Jernigan DB, Lanciotti R, Petersen LR, Goldsmith C, Rollin PE, Shieh WJ, Guarner J, Zaki SR.

Am J Clin Pathol. 2004 Jan;121(1):26-31.

PMID:
14750237
47.

The psychoanalytic treatment of a man suffering with ulcerative colitis.

CUSHING MM.

J Am Psychoanal Assoc. 1953 Jul;1(3):510-8. No abstract available.

PMID:
13061351
48.

A concept of the genesis of hostility.

CUSHING JG, CUSHING MM.

Bull Menninger Clin. 1949 May;13(3):94-9. No abstract available.

PMID:
18144376

Supplemental Content

Loading ...
Support Center